← All organizations
Highest phase reached
Phase 3
First clinical trial
May 7, 2023Last known activity
Jan 1, 2026
Timeline
2020s
- Jun 1, 2020
NeuroDawn Pharmaceutical Co., Ltd.— Founded
Drugs by trial phase (12 distinct, 13 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Recent trials (14)
- NCT07275762Lead sponsorPhase 2Jan 1, 2026
- NCT07203521Lead sponsorPhase 2Nov 1, 2025
- NCT07166380CollaboratorPhase 1/Phase 2Sep 20, 2025
- NCT07166380Lead sponsorPhase 1/Phase 2Sep 20, 2025
- NCT07040085CollaboratorPhase 3Aug 5, 2025
- NCT07055412Lead sponsorPhase 1Jul 10, 2025
- NCT07068841Lead sponsorPhase 1May 18, 2025
- NCT06935721CollaboratorPhase 1Mar 28, 2025
- NCT06770491Lead sponsorPhase 1Jan 6, 2025
- NCT06517173CollaboratorPhase 3Jul 24, 2024
- NCT06138834CollaboratorPhase 2Nov 30, 2023
- NCT06429384CollaboratorPhase 2Jun 4, 2023
- NCT05836740CollaboratorPhase 3May 19, 2023
- NCT05836753CollaboratorPhase 2May 7, 2023
Details
- Founded
- Nanjing, CN Jun 1, 2020
- Last known activity
- Jan 1, 2026